Linked Life Data

9139345

Source:http://linkedlifedata.com/resource/pubmed/id/9139345

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
1997-5-8
pubmed:abstractText
Embolic complications are very common in patients with atrial fibrillation. Patients over 60 years with organic heart disease, arterial hypertension, diabetes mellitus and previous embolic complications are prone to embolic complications. In these high risk groups anticoagulation should be introduced when no contraindications exist. Long term anticoagulation therapy should be evaluated for each patient individually balancing pro and contra. For patients with a low risk of embolism aspirin is a valuable alternative to anticoagulation. Patients below 60 years without heart disease and without additional risks do not need any therapy.
pubmed:language
ger
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1661-8157
pubmed:author
pubmed:issnType
Print
pubmed:day
11
pubmed:volume
86
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
258-60
pubmed:dateRevised
2008-6-10
pubmed:meshHeading
pubmed:year
1997
pubmed:articleTitle
[Should every patient with atrial fibrillation get anticoagulants?].
pubmed:affiliation
Departement für Innere Medizin, Universitätsspital Zürich.
pubmed:publicationType
Journal Article, English Abstract